The Alliance for Connected Care submitted comments in response to the request for information from the Treatments Subcommittee of the Healthy Future Task Force regarding medical innovation to supercharge the availability and development of life-saving treatments, devices, and diagnostics, while addressing rising costs to patients.
The Alliance specifically commented on the question under “Goal 4: Increase access to medical innovation” about decentralizing clinical trials in order to expand access to innovative treatments to patients through remote monitoring.
The Alliance believes continuing to modernize and decentralize clinical trials is critical for creating opportunities for more diversity and patient engagement. Obviating the need for travel time, lost wages and childcare/eldercare through use of digital technologies will significantly increase the pool of potential participants in clinical trials across geographies. However, state licensing limitations continue to present a barrier to decentralizing clinical trials, and effectively prohibit clinicians working on clinical trials from recruiting patients from outside the state where the clinician is licensed.
To read the full letter, click here or see below: